Caplin Point Laboratories LimitedNSE: CAPLIPOINT

Press Release Jan 22 2021

Jan 22, 2021 at 5:05 PM UTC

Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated January 22, 2021, titled "CAPLIN STERILES GETS USFDA APPROVAL FOR ARGATROBAN INJECTION".

View Attachment